This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Implicit parasitic Sepsis
AB1_SEPSIS_PARAS_IMPL
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
56330 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
163 |
4. Check minimum number of eventsNone |
163 |
5. Include endpointsNone |
163 |
6. Filter based on genotype QC (FinnGen only) |
163 |
Control definitions (FinnGen only)
- Control exclude
- AB1_SEPSIS_EXPLICIT, AB1_SEPSIS_IMPLICIT
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Implicit parasitic Sepsis
based on the number of shared cases.
Similar with more cases:
- Implicit Sepsis
- Condition for Implicit Sepsis (Organ dysfunction codes)
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 163 | 91 | 72 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 53.25 | 50.84 | 56.28 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 151
- Matched controls
- 1510
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R55
ICD-10 Finland
Syncope and collapse
39.0
58.2
75
37
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
8.2
23.2
58
106
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
14.5
21.5
37
33
A06.9
ICD-10 Finland
Amoebiasis, unspecified
+∞
18.1
17
*
A07.1
ICD-10 Finland
Giardiasis [lambliasis]
+∞
15.9
15
*
A07.8
ICD-10 Finland
Other specified protozoal intestinal diseases
+∞
15.9
15
*
J01MA12
ATC
levofloxacin; systemic
5.8
15.9
50
118
P01AB01
ATC
metronidazole; oral, rectal
4.1
14.9
87
379
N17.9
ICD-10 Finland
Acute renal failure, unspecified
59.2
14.1
16
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.2
14.1
67
240
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.9
14.0
91
425
C03CA01
ATC
furosemide; systemic
4.1
13.5
65
233
AA1AD
NOMESCO Finland
CT of head and brain
4.3
13.2
59
197
A07.9
ICD-10 Finland
Protozoal intestinal disease, unspecified
141.2
12.6
13
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
5.5
12.6
40
93
R06.0
ICD-10 Finland
Dyspnoea
3.8
11.9
61
226
TPH04
NOMESCO Finland
Cathetrisation of vein
4.1
11.2
50
163
XF400
NOMESCO Finland
ECG with 12 standard connections
4.2
10.8
45
138
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.6
10.1
53
196
H02AB06
ATC
prednisolone; systemic
3.0
9.7
87
469
A06.0
ICD-10 Finland
Acute amoebic dysentery
106.4
9.5
10
*
R51.80
ICD-10 Finland
Headache
4.2
9.5
38
111
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.9
9.2
41
132
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
9.6
9.1
18
21
R50.9
ICD-10 Finland
Fever, unspecified
4.1
8.9
36
106
R11
ICD-10 Finland
Nausea and vomiting
6.0
8.8
24
46
C07AB07
ATC
bisoprolol; oral
2.9
8.8
84
461
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
6.3
8.7
23
42
A02BC01
ATC
omeprazole; systemic
3.1
8.6
56
240
A41.9
ICD-10 Finland
Sepsis, unspecified
+∞
8.4
8
*
A10AE04
ATC
insulin glargine; parenteral
5.3
8.3
25
54
E0000UV
ATC
NA
2.8
8.1
75
397
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.2
8.0
47
185
L28
ICPC
Limited function/disability (L)
3.9
8.0
34
104
J01MA02
ATC
ciprofloxacin; systemic
2.8
8.0
69
349
E86
ICD-10 Finland
Volume depletion
16.1
7.9
12
8
R53
ICD-10 Finland
Malaise and fatigue
3.3
7.8
43
162
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.5
7.8
39
137
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.7
7.7
36
119
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.3
7.7
23
49
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
7.8
7.7
17
24
N05CF01
ATC
zopiclone; oral
2.8
7.7
62
299
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.5
7.7
27
69
A06AD11
ATC
lactulose; oral
4.2
7.6
29
80
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
4.1
7.6
30
86
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.0
7.6
24
55
SPAT1262
SPAT
Handing over of treatment supplies
3.5
7.5
37
128
D64.9
ICD-10 Finland
Anaemia, unspecified
4.7
7.4
25
61
A02BC03
ATC
lansoprazole; oral
2.8
7.4
59
282
103
Kela drug reimbursment
Diabetes, insulin-treated
2.9
7.4
52
229
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
7.4
34
111
N30.0
ICD-10 Finland
Acute cystitis
4.0
7.3
30
89
N05BA01
ATC
diazepam; systemic, rectal
3.7
7.1
32
103
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
8.2
7.1
15
20
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
7.1
65
337
J01FF01
ATC
clindamycin; systemic
2.8
7.1
53
244
S06.0
ICD-10 Finland
Concussion
4.3
7.0
26
70
N05AH04
ATC
quetiapine; oral
3.5
7.0
34
116
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
4.1
7.0
27
76
A28
ICPC
Limited function/disability NOS
3.5
6.9
33
111
K92.1
ICD-10 Finland
Melaena
7.8
6.9
15
21
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
6.0
6.9
18
33
J96.1
ICD-10 Finland
Chronic respiratory failure
42.0
6.8
8
*
WX002
NOMESCO Finland
Sedation and analgesia
3.0
6.8
43
175
UJF32
NOMESCO Finland
Coloscopy
2.7
6.7
53
248
C10AA05
ATC
atorvastatin; oral
2.5
6.7
68
369
J01MA06
ATC
norfloxacin; oral
3.4
6.6
33
115
XF404
NOMESCO Finland
Ambulatory ECG
4.3
6.6
24
64
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
4.8
6.6
21
49
R5140
NOMESCO Finland
Monitoring the use of the aid
4.1
6.5
25
70
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
15.2
6.5
10
7
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
3.0
6.5
42
174
JN4AD
NOMESCO Finland
Body CT examination
4.7
6.4
21
50
M01AE02
ATC
naproxen; oral, rectal
2.4
6.4
93
602
R06AE07
ATC
cetirizine; oral
2.5
6.4
72
409
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
6.4
30
100
N03AX09
ATC
lamotrigine; oral
6.3
6.3
16
28
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
+∞
6.3
6
*
1369X
ICD-9 Finland
Other and unspecified infectious and parasitic diseases, Unspecified infectious and parasitic diseases
+∞
6.3
6
*
B58.9
ICD-10 Finland
Toxoplasmosis, unspecified
+∞
6.3
6
*
B50.9
ICD-10 Finland
Plasmodium falciparum malaria, unspecified
+∞
6.3
6
*
H32.0*B58.0
ICD-10 Finland
Toxoplasma chorioretinitis
+∞
6.3
6
*
R40.2
ICD-10 Finland
Coma, unspecified
+∞
6.3
6
*
B01AA03
ATC
warfarin; systemic
2.9
6.3
41
171
R07.4
ICD-10 Finland
Chest pain, unspecified
2.6
6.2
51
245
A04
ICPC
Weakness/tiredness general
3.3
6.2
31
108
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.9
6.2
41
173
H04AA01
ATC
glucagon; nasal, parenteral
9.2
6.2
12
14
R4110
NOMESCO Finland
Physiotherapy
2.6
6.2
52
250
I44.2
ICD-10 Finland
Atrioventricular block, complete
13.3
6.2
10
8
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.2
6.0
22
59
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
32
36
10.82
26.88
3.4
1.5
—
—
—
0
0
27
40
7.89
18.02
1.4
1.6
1.2
8.1
ug/l
0.46
21
34
35
75
5.67
16.30
2.3
1.6
—
—
—
0
0
55
175
4.23
15.81
3.1
1.7
—
—
—
0
0
50
159
4.09
14.24
3.1
2.1
2.2
2.3
g/l
0.87
45
141
39
105
4.57
13.80
6.2
4.3
1.2
2.1
mmol/l
0.80
32
83
47
151
3.97
13.10
3.3
2.1
18.4
23.4
%
1.49
40
134
91
448
3.33
12.98
5.0
2.8
—
—
—
0
0
52
183
3.70
12.66
3.1
2.1
10.5
14.0
umol/l
1.92
46
161
40
118
4.17
12.49
13.5
4.9
1.2
1.1
mmol/l
0.04
34
93
40
118
4.17
12.49
2.9
1.6
—
—
—
0
0
102
546
3.32
12.49
7.7
3.8
33.9
36.2
g/l
3.44
97
512
56
209
3.56
12.45
3.8
3.3
615.7
195.2
ng/l
0.71
46
161
40
119
4.13
12.34
2.8
1.6
—
—
—
0
0
109
611
3.37
12.26
14.6
5.3
1.2
1.2
mmol/l
1.92
96
508
124
753
3.70
12.20
10.0
3.9
6.9
6.6
mmol/l
0.53
118
689
15
17
9.62
12.19
2.2
1.7
—
—
—
0
0
13
12
11.69
12.11
1.8
1.4
—
—
—
0
0
16
20
8.76
12.10
2.3
1.6
—
—
—
0
0
16
20
8.76
12.10
2.4
1.7
—
—
—
0
0
31
77
4.74
12.03
10.5
5.7
25.5
24.8
mmol/l
0.68
31
77
76
351
3.18
11.82
4.9
2.7
0.3
0.3
e6/l
0.14
55
251
12
11
11.70
11.19
2.3
1.5
—
—
—
0
0
25
56
5.09
10.91
16.0
5.3
24.9
24.6
mmol/l
0.19
25
50
62
276
3.01
9.99
2.5
2.0
1.4
1.0
mg/l
0.48
52
216
116
753
2.87
8.70
14.1
9.5
4.3
4.0
e9/l
0.49
103
669
14
22
6.87
8.68
2.1
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
26
6.25
8.49
3.9
2.0
0.4
0.4
u/ml
—
8
13
28
84
3.82
8.38
4.2
2.3
1.7
1.9
mmol/l
0.07
22
63
36
128
3.33
8.35
3.2
2.9
6.3
7.7
umol/l
0.51
30
110
23
60
4.30
8.30
2.3
1.7
—
—
—
0
0
88
510
2.58
8.11
2.6
1.9
104.3
91.9
pmol/l
1.51
53
243
11
14
8.35
8.09
1.9
1.5
—
—
—
0
0
70
368
2.58
7.86
4.4
3.1
1381.4
1462.6
ng/l
0.09
61
302
47
206
2.80
7.53
4.3
2.4
3.5
0.9
e6/l
0.42
24
115
137
1008
3.25
7.52
13.7
6.6
75.4
79.0
u/l
0.67
132
932
62
313
2.58
7.51
4.8
2.8
352.7
5064.4
umol/l
1.23
53
268
44
188
2.84
7.38
4.5
2.6
4.8
2.0
e6/l
0.45
21
99
21
56
4.16
7.35
3.0
2.0
1.6
1.5
g/l
0.26
21
45
73
408
2.43
7.02
3.9
2.1
54.0
57.3
u/l
0.43
65
371
16
37
4.69
6.66
1.4
1.3
—
—
—
0
0
89
553
2.34
6.62
4.3
2.7
121.5
106.9
ug/l
0.31
83
500
85
519
2.33
6.57
3.0
2.2
73.5
76.1
nmol/l
0.46
78
448
59
307
2.44
6.56
2.9
1.9
2.7
3.0
mg/l
0.48
54
256
83
502
2.33
6.55
5.3
3.9
52.1
46.4
ng/l
0.10
65
345
49
234
2.56
6.54
2.0
1.7
875.5
1173.4
nmol/l
1.80
36
169
25
82
3.42
6.52
5.2
3.3
100.9
85.0
ng/l
0.42
19
73
10
7
15.10
6.48
2.4
1.3
—
—
—
0
0
59
310
2.42
6.40
2.0
1.5
17.8
21.4
nmol/l
1.30
53
248
11
19
6.14
6.19
1.9
1.5
—
—
—
0
0
10
8
13.21
6.17
2.4
1.4
—
—
—
0
0
11
20
5.83
5.89
1.4
1.4
—
—
—
0
0
74
443
2.23
5.81
4.5
3.1
2.3
2.4
mmol/l
2.00
68
385
21
69
3.35
5.45
1.9
1.2
—
—
—
0
0
28
111
2.84
5.30
2.1
2.2
8.9
6.1
ug/l
0.43
23
96
14
35
4.28
5.29
3.5
2.2
—
—
—
0
0
9
9
10.50
5.09
1.9
1.2
—
—
—
0
0
93
641
2.05
4.78
6.3
3.5
0.0
0.0
estimate
0.00
18
129
15
43
3.74
4.74
1.6
1.2
—
—
—
0
0
19
64
3.23
4.73
21.7
5.5
0.7
0.7
%
0.08
19
64
19
65
3.18
4.62
21.3
5.5
1.4
1.5
%
0.13
19
65
7
5
14.53
4.61
1.6
2.0
—
—
—
0
0
7
5
14.53
4.61
1.6
2.0
—
—
—
0
0
92
637
2.02
4.61
8.7
4.6
0.0
0.0
estimate
0.00
19
137
10
21
5.01
4.59
2.2
1.4
—
—
—
0
0
32
146
2.48
4.59
1.8
1.7
1.7
1.5
%
0.76
26
121
8
8
10.43
4.57
1.5
1.6
—
—
—
0
0
91
630
2.01
4.54
6.4
3.5
0.0
0.0
estimate
0.00
19
136
124
969
2.17
4.32
6.9
3.8
15.3
10.9
mm/h
1.74
119
875
9
13
7.25
4.22
2.7
2.0
—
—
—
0
0
14
42
3.55
4.15
1.6
1.2
—
—
—
0
0
14
42
3.55
4.15
3.1
1.8
—
—
—
0
0
8
10
8.34
4.11
1.6
1.6
—
—
—
0
0
9
14
6.73
4.04
2.7
1.9
—
—
—
0
0
9
14
6.73
4.04
2.7
1.9
—
—
—
0
0
9
14
6.73
4.04
2.7
1.9
—
—
—
0
0
50
290
2.04
4.01
4.4
2.1
—
—
—
0
0
50
292
2.03
3.93
1.6
1.2
1.2
1.4
u/ml
—
10
75
9
15
6.28
3.87
2.7
1.9
—
—
—
0
0
9
15
6.28
3.87
2.7
1.9
—
—
—
0
0
6
5
12.38
3.79
1.8
1.0
75.0
92.2
%
—
6
5
6
5
12.38
3.79
1.7
2.0
—
—
—
0
0
6
5
12.38
3.79
1.7
2.0
—
—
—
0
0
14
45
3.31
3.75
2.6
1.9
—
—
—
0
0
8
12
6.95
3.72
1.6
1.5
—
—
—
0
0
8
12
6.95
3.72
2.1
1.6
—
—
—
0
0
18
68
2.85
3.70
1.3
1.4
—
—
—
0
0
107
816
1.91
3.69
3.6
3.0
—
—
—
0
0
151
1312
3.05
3.68
34.1
12.3
26.8
21.7
mg/l
1.07
130
1030
14
47
3.16
3.50
1.2
2.7
—
—
—
0
0
38
211
2.04
3.38
1.1
1.2
31.8
31.4
iu/ml
—
6
65
43
250
1.98
3.37
2.1
1.6
436.2
456.8
pmol/l
0.22
38
206
6
7
8.84
3.29
1.8
1.3
—
—
—
0
0
11
33
3.50
3.25
3.5
4.5
206.8
196.7
%
0.11
11
33
16
62
2.75
3.15
2.2
3.5
1.0
1.2
%
0.59
16
62
120
980
1.85
3.00
4.6
4.0
15.0
14.8
pmol/l
0.18
109
875
5
5
10.26
3.00
1.4
1.8
—
—
—
0
0
5
5
10.26
3.00
1.4
1.8
—
—
—
0
0
17
70
2.59
2.99
1.0
1.0
—
—
—
0
0
81
592
1.73
2.98
7.1
3.7
—
—
—
0
0
25
126
2.16
2.84
2.3
2.0
358.6
367.5
nmol/l
0.09
19
116
42
257
1.85
2.80
3.6
2.7
2.4
2.4
mmol/l
1.35
36
230
5
6
8.54
2.77
1.6
2.2
15.0
11.0
u/l
—
5
6
5
6
8.54
2.77
3.8
5.2
818.2
1113.0
u/ml
—
5
6
5
6
8.54
2.77
1.4
1.7
—
—
—
0
0
136
1174
1.96
2.62
34.3
13.1
39.1
39.8
%
0.47
97
836
138
1198
1.99
2.60
6.1
4.6
2.0
2.9
mu/l
0.45
132
1063
8
20
4.15
2.60
1.3
1.5
—
—
—
0
0
8
20
4.15
2.60
1.3
1.5
—
—
—
0
0
8
20
4.15
2.60
1.9
1.5
—
—
—
0
0
6
11
5.61
2.56
1.2
1.2
—
—
—
0
0
7
18
4.01
2.28
1.1
1.7
—
—
—
0
0
5
9
5.69
2.23
1.6
1.8
—
—
—
0
0
5
9
5.69
2.23
1.6
1.8
—
—
—
0
0
5
9
5.69
2.23
1.6
1.8
—
—
—
0
0
6
14
4.41
2.17
4.0
1.8
—
—
—
0
0
148
1346
2.08
2.00
41.0
13.9
138.9
139.7
mmol/l
3.30
148
1303
5
11
4.65
1.95
1.0
1.2
—
—
—
0
0
5
11
4.65
1.95
4.6
2.0
—
—
—
0
0
6
16
3.85
1.95
1.0
1.1
—
—
—
0
0
148
1350
2.05
1.92
41.4
14.0
4.0
4.0
mmol/l
0.50
148
1306
7
22
3.28
1.90
1.3
1.1
—
—
—
0
0
5
12
4.26
1.83
1.4
1.2
—
—
—
0
0
150
1379
2.10
1.83
37.4
14.5
88.8
76.5
umol/l
1.56
150
1379
50
360
1.56
1.78
7.0
3.8
0.0
0.0
estimate
0.00
19
131
8
30
2.75
1.75
2.1
1.2
—
—
—
0
0
8
30
2.75
1.75
1.3
1.4
—
—
—
0
0
125
1100
1.58
1.69
36.8
15.4
14.0
13.7
%
1.90
125
1077
8
33
2.50
1.56
1.1
1.1
—
—
—
0
0
5
15
3.40
1.53
1.0
1.1
—
—
—
0
0
5
15
3.40
1.53
3.0
4.6
—
—
—
0
0
5
15
3.40
1.53
1.4
1.7
—
—
—
0
0
30
199
1.62
1.49
1.2
1.2
1.5
6.8
u/ml
—
7
85
136
1234
1.62
1.47
30.7
12.1
78.3
80.9
ml/min/173m2
0.54
116
990
7
28
2.57
1.47
1.1
1.4
—
—
—
0
0
5
17
3.00
1.37
1.0
1.1
—
—
—
0
0
5
17
3.00
1.37
1.0
1.1
—
—
—
0
0
6
24
2.56
1.31
1.3
1.9
—
—
—
0
0
11
55
2.07
1.30
5.1
1.6
—
—
—
0
0
62
493
1.42
1.30
7.4
3.6
—
—
—
0
0
9
44
2.11
1.29
2.1
1.8
—
—
—
0
0
133
1212
1.53
1.28
7.9
5.6
41.2
39.6
mmol/mol
0.92
128
1117
8
36
2.28
1.26
9.4
2.0
—
—
—
0
0
5
19
2.68
1.22
2.6
1.2
0.3
0.4
nmol/l
—
5
12
135
1238
1.53
1.22
4.7
3.9
1.3
1.3
mmol/l
0.49
126
1112
22
143
1.62
1.19
7.0
3.0
—
—
—
0
0
46
355
1.41
1.13
1.9
1.6
1.6
1.4
mmol/l
0.69
38
296
8
41
2.00
1.10
1.5
1.8
—
—
—
0
0
32
236
1.44
1.00
1.4
1.6
—
—
—
0
0
140
1310
1.49
0.96
5.9
4.9
2.5
2.7
mmol/l
1.95
132
1189
12
70
1.77
0.95
5.4
1.7
—
—
—
0
0
137
1282
1.43
0.89
5.3
4.4
4.3
4.6
mmol/l
3.75
128
1176
136
1274
1.41
0.85
5.2
4.4
1.4
1.5
mmol/l
1.95
125
1156
14
89
1.63
0.84
2.5
3.3
55.4
64.8
ml/min/173m2
—
8
35
19
131
1.51
0.83
3.6
2.1
—
—
—
0
0
5
29
1.75
0.64
2.0
1.7
—
—
—
0
0
134
1277
1.28
0.53
5.6
4.4
6.2
5.9
mmol/l
1.36
121
1150
151
1467
1.40
0.46
48.0
18.6
129.4
135.7
g/l
4.87
151
1438
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
20
164
1.25
0.34
18.1
7.2
—
—
—
0
0
18
146
1.26
0.34
4.1
2.2
—
—
—
0
0
16
186
0.85
0.20
1.6
1.4
—
—
—
0
0
34
338
1.01
0.00
3.6
4.3
21.9
21.7
%
0.02
12
153
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: AB1_SEPSIS_PARAS_IMPL – Implicit parasitic Sepsis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).